The transgenic core will provide injection services for the construction of transgenic mice by injection of DNA into fertilized oocytes and mice carrying targeted mutations by injection of ES cells into mouse blastocysts. It will also provide Center members with promoter/enhancer constructs for directing gene expression to different parts of the GI tract that have been developed in Dr. Gordon's laboratory. It will also provide consultations on embryonic stem cell manipulations. Established embryonic stem cell lines and fibroblast feeder cells will be supplied by an existing separate facility, Dr. Ley's stem cell core (Cancer Center), which will do the transfection and expansion of ES cells. This stem cell core does not provide injection services. The proposed facility will be developed from a mini-facility now operated by the Ornitz and Gordon laboratories. These laboratories have had a high level of success deriving transgenic, chimeric transgenic and knockout mice, so it is predicted that the facility will be efficient. The Transgenic Mouse and Stem Cell Core is located in a mouse barrier facility across the street from the medical center. There appears to be ample space for both the injection stations and no limitation on space for housing mice. The Core is equipped with three injection stations. Upon receiving funding, trained technicians from the Gordon and Orvitz laboratories will be recruited to work full time for the Core, with both technicians responsible for microinjections and animal husbandry.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK052574-02
Application #
6410329
Study Section
Special Emphasis Panel (ZDK1)
Project Start
2000-12-01
Project End
2001-11-30
Budget Start
Budget End
Support Year
2
Fiscal Year
2001
Total Cost
$180,000
Indirect Cost
Name
Washington University
Department
Type
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Funk, Steven D; Bayer, Raymond H; Malone, Andrew F et al. (2018) Pathogenicity of a Human Laminin ?2 Mutation Revealed in Models of Alport Syndrome. J Am Soc Nephrol 29:949-960
Schnadower, David; Tarr, Phillip I; Casper, T Charles et al. (2018) Lactobacillus rhamnosus GG versus Placebo for Acute Gastroenteritis in Children. N Engl J Med 379:2002-2014
VanDussen, Kelli L; Stojmirovi?, Aleksandar; Li, Katherine et al. (2018) Abnormal Small Intestinal Epithelial Microvilli in Patients With Crohn's Disease. Gastroenterology 155:815-828
Davidson, Nicholas O (2018) Tie-ing up angiogenesis to treat NASH. Hepatology :
Engelstad, Holly J; Barron, Lauren; Moen, Joseph et al. (2018) Remnant Small Bowel Length in Pediatric Short Bowel Syndrome and the Correlation with Intestinal Dysbiosis and Linear Growth. J Am Coll Surg 227:439-449
Rusconi, B; Jiang, X; Sidhu, R et al. (2018) Gut Sphingolipid Composition as a Prelude to Necrotizing Enterocolitis. Sci Rep 8:10984
Knoop, Kathryn A; Newberry, Rodney D (2018) Goblet cells: multifaceted players in immunity at mucosal surfaces. Mucosal Immunol 11:1551-1557
Choi, Jaebok; Cooper, Matthew L; Staser, Karl et al. (2018) Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease. Leukemia 32:2483-2494
Mills, Jason C; Samuelson, Linda C (2018) Past Questions and Current Understanding About Gastric Cancer. Gastroenterology 155:939-944
Vishy, Courtney E; Swietlicki, Elzbieta A; Gazit, Vered et al. (2018) Epimorphin regulates the intestinal stem cell niche via effects on the stromal microenvironment. Am J Physiol Gastrointest Liver Physiol 315:G185-G194

Showing the most recent 10 out of 899 publications